ClinicalLSL60101 compound may produce efficaciousness for Alzheimer’s disease and neuroinflammationThe drug's test on rodents yielded improvements in cognitive deficits and may prove to be beneficial for treating certain neurogenerative diseases. Read More
ClinicalNew experimental treatment of CpG oligodeoxynucleotides shows promise for Alzheimer’s diseaseThe results had been published in the peer-reviewed journal Brain. Read More
ClinicalNew experimental drug may impede amyloid pathology associated with Alzheimer’s diseaseThe findings were publicized in the Journal of Experimental Medicine. Read More
